Bora Pharmaceuticals Co., LTD.

TWSE:6472 株式レポート

時価総額:NT$83.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Bora Pharmaceuticals マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Bobby Sheng

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間9.8yrs
CEOの所有権6.9%
経営陣の平均在職期間6.8yrs
取締役会の平均在任期間8.1yrs

経営陣の近況

Recent updates

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

CEO(最高経営責任者

Bobby Sheng

9.8yrs

在職期間

Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Pao-Shi Sheng
Chairmanno dataデータなし6.86%
NT$ 5.7b
Alice Wang
CFO of HQ & APAC11.4yrsデータなしデータなし
Ellen Chen
Corporate Human Resource Director2.4yrsデータなしデータなし
Shih-Min Chen
VP & Director11.2yrsデータなし1.11%
NT$ 922.5m
Sally Langa
Senior VP of Marketing and Sales - CDMO Businessno dataデータなしデータなし
Marcel Vieno
CFO of North Americano dataデータなしデータなし
Tom Chang
Senior Vice President of Taiwan Site Operations1.4yrsデータなしデータなし
Xiu-Rong Zhang
Deputy General Managerno dataデータなし0.010%
NT$ 8.4m
Zhen-Tang Zhang
Deputy General Managerno dataデータなし0.097%
NT$ 81.0m

6.8yrs

平均在職期間

経験豊富な経営陣: 6472の経営陣は経験豊富で経験豊富です(平均在職期間は6.8年)。


取締役

名称ポジション在職期間報酬所有権
Pao-Shi Sheng
Chairman9.8yrsデータなし6.86%
NT$ 5.7b
Shih-Min Chen
VP & Director9.8yrsデータなし1.11%
NT$ 922.5m
Jui-Yi Lin
Independent Director9.2yrsデータなしデータなし
Shang-Hung Shen
Director9.8yrsデータなしデータなし
Kuan-Pai Chen
Director5yrsデータなしデータなし
Ming-Jung Lai
Independent Director7yrsデータなしデータなし
Yi-Chin Lee
Independent Director7yrsデータなし0.032%
NT$ 26.8m
Hsin-I Lin
Independent Directorless than a yearデータなし0.00099%
NT$ 825.7k

8.1yrs

平均在職期間

経験豊富なボード: 6472の 取締役会経験豊富 であると考えられます ( 8.1年の平均在任期間)。